Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial-Reference-Cited by-同舟云学术

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Published:2016-07 Issue:10039 Volume:388 Page:31-44
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wenzel Sally,Castro Mario,Corren Jonathan,Maspero Jorge,Wang Lin,Zhang Bingzhi,Pirozzi Gianluca,Sutherland E Rand,Evans Robert R,Joish Vijay N,Eckert Laurent,Graham Neil M H,Stahl Neil,Yancopoulos George D,Louis-Tisserand Mariana,Teper Ariel

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment;Peters;Respir Med,2006

2. Predicting asthma exacerbations in children;Forno;Curr Opin Pulm Med,2012

3. Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations;Bateman;J Allergy Clin Immunol,2015

4. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

5. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies;Wenzel;Lancet,2007

Cited by 765 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choosing the right biologic treatment for individual patients with severe asthma – Lessons learnt from Picasso;Respiratory Medicine;2024-11

2. Dupilumab responder types and predicting factors in patients with type 2 severe asthma: A real-world cohort study;Respiratory Medicine;2024-09

3. Comparative safety of monoclonal antibodies in chronic inflammatory airway diseases (chronic sinusitis with nasal polyposis and asthma): A network meta-analysis;International Immunopharmacology;2024-09

4. Biologics in Asthma;Immunology and Allergy Clinics of North America;2024-09

5. Higher prevalence of dupilumab‐induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysis;Clinical and Translational Allergy;2024-08